Anti‐TIF‐1γ‐associated DM typically presents with proximal limb weakness accompanied by severe skin changes, moderately elevated CK levels, and absence of interstitial lung disease (ILD) (7). This evidence concerns the gene TRIM33 and dermatomyositis.